United Therapeutics Corporation
United Therapeutics Corporation (UTHR) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · UTHR · as of Sep 30, 2025
Ownership Breakdown
751
Institutional Holders
▲ 57 vs Q2
$17.18B
Total Inst. Value
▲ $4.52B vs Q2
42.45M
Shares Outstanding
freeFloat 91.70%
40.98M
13F Shares Held
▼ 3.06M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
UTHR largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. pharmaceutical preparations | 5.35M | 11.87% | 11.87% | $2.24T | Nov 12, 2025 | ▲ 19.3K |
VANGUARD GROUP INC pharmaceutical preparations | 4.42M | 9.80% | 9.80% | $1.85T | Nov 7, 2025 | ▼ 30.2K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 2.17M | 4.82% | 4.82% | $911.11B | Nov 13, 2025 | ▲ 54.3K |
AVORO CAPITAL ADVISORS LLC pharmaceutical preparations | 2.02M | 4.48% | 4.48% | $847.74B | Nov 14, 2025 | ▼ 347.8K |
STATE STREET CORP pharmaceutical preparations | 1.92M | 4.26% | 4.26% | $805.98B | Nov 14, 2025 | ▼ 244.9K |
WELLINGTON MANAGEMENT GROUP LLP pharmaceutical preparations | 1.40M | 3.10% | 3.10% | $586.38B | Nov 14, 2025 | ▼ 44.2K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 1.25M | 2.77% | 2.77% | $522.91B | Nov 12, 2025 | ▲ 49.3K |
AQR CAPITAL MANAGEMENT LLC pharmaceutical preparations | 986.5K | 2.19% | 2.19% | $413.54B | Nov 14, 2025 | ▼ 286.7K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 824.3K | 1.83% | 1.83% | $345.55B | Nov 14, 2025 | ▲ 652.1K |
DARWIN GLOBAL MANAGEMENT, LTD. pharmaceutical preparations | 748.5K | 1.66% | 1.66% | $317.62B | Nov 14, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
23
Increased
+4.36M shares3
New Positions
first time holders24
Decreased
−2.52M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.84M
+4.36M / −2.52M
Net new holders
+2
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
UTHR insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
75
Buy transactions
821
Sell transactions
0.09
Buy/Sell ratio
$2M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 120 | $539.64 | $64.8K | 28.8K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 480 | $541.14 | $259.7K | 28.3K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 440 | $542.78 | $238.8K | 27.8K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 1,086 | $544.11 | $590.9K | 26.8K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 1,545 | $544.94 | $841.9K | 25.2K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 1,129 | $545.89 | $616.3K | 24.1K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 1,033 | $547.00 | $565.1K | 23.0K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 2,749 | $548.04 | $1.51M | 20.3K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 1,298 | $549.06 | $712.7K | 19.0K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 120 | $550.48 | $66.1K | 18.9K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
United Therapeutics Corporation (UTHR) is primarily owned by institutional investors, who hold approximately 96.5% of total shares outstanding. Company insiders own approximately 8.30%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of United Therapeutics Corporation is BLACKROCK, INC., holding approximately 5.35 million shares — equal to 11.87% of outstanding shares — as of September 30, 2025.
A total of 751 institutional investors currently hold UTHR stock, with a combined institutional value of approximately $17.18 billion as of the most recent 13F filing period.
Frequently asked questions
UTHR ownershipUnited Therapeutics Corporation (UTHR) is primarily owned by institutional investors, who hold approximately 96.5% of shares. The largest shareholder is BLACKROCK, INC. with a 11.87% stake. Company insiders hold 8.30%. Data sourced from SEC Form 13F as of September 30, 2025.